FDA Approved: FAMOTIDINE — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved Biocon Pharma Inc.'s original ANDA for famotidine, enabling a generic version of the H2 blocker for the treatment and prevention of duodenal ulcers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease

Drugs mentioned

• Famotidine (famotidine)

Snippet

ORIG AP for FAMOTIDINE (FAMOTIDINE)